C71T
CANCELLED SECTION 71
17/04/2026
Voltar para busca
Dado oficial do USPTO
ATTYLOID
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ATTYLOID
ST13
US500000079232535Classe
1, 9, 42, 44
Pedido
79232535
Registro
5870381
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
12/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 9, 42, 44
Data de depósito
01/09/2017
Data de registro
01/10/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/04/2026
Última transação
12/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
98
Localização do titular
DE
Examinador
PEREZ, STEVEN M
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
attyloid GmbH
P. W. (pessoa física)
Representantes
Angel Herrera, Jr. Abel Law Group, LLP
Classificação técnica
Classes Nice
Classe 1Classe 9Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical substances for the production of pharmaceuticals; esters of fatty acids being chemical additives for use in the manufacture of pharmaceuticals; preservatives for pharmaceutical compounds; antimicrobial preservatives for pharmaceutical compounds; chemicals for the preparation being manufacturing and production of pharmaceuticals; antioxidants for the production of pharmaceutical products; chemical compounds for the preparation being manufacturing of pharmaceutical products; esters being viscose chemicals for the production of pharmaceutical products; preservatives for use in the pharmaceutical industry; softening agents being chemical agents for manufacturing for use during the preparation of pharmaceuticals; chemical products for use in the pharmaceutical industrychemical additives for use in the manufacture of pharmaceuticals; active chemical ingredients for the use during the preparation being manufacturing of pharmaceuticals; biochemical compounds for scientific purposes; biochemical productsnamely polypeptides for in vitro research applications; biochemical productschemical reagents for in vitro genetic technology; reagents for use in scientific apparatus for chemical and biological analysis; diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; biochemicalsmonoclonal antibodies for in vitro scientific or research use
Classe 9
Research laboratory analyzers for measuringtesting and analyzing blood and other body fluids; analyzing devicesnot for medical purposenamely pH meters; computer software for the medical sectornamely medical software for controlling and managing patient medical information; computer software for use for systems as support for medical decisionsmedical software for processing and displaying images on ultrasound medical imaging machines; diagnostic testing devices for foodstuffpH meters; diagnostic devicesnot for medical purpose namelydiagnostic apparatus for testing food; diagnostic devices for scientific purpose namelydiagnostic apparatus for the detection of pathogens for laboratory or research use; fluorescence analyzers namelyscientific instrument in the nature of fluorescence detector for microscopy; laboratory devices for detecting proteinsimmunostaining devices not for medical purpose; lasersnot for medical purpose; lasers for scientific purpose; microscopes for medical purpose; microscopes; particle detector devices for detecting airborne particles; particle classification devices for identifying airborne particles; physical measuring instrumentsexcept for medical purpose namelyinstruments for measuring length; physical devices and instruments namely seismometers; physical analyzing devices not for medical purposenamely pH meterstesting probesexcept for medical purposeprobes for testing soil moisture levels
Classe 42
Development of pharmaceutical compounds and drugs; research and development of vaccine and drugs; pharmaceutical product development in relation to drugs; pharmaceutical researchresearch regarding pharmaceuticals; conducting of quality control tests on pharmaceutical products; medical and pharmaceutical research services; pharmaceutical research and development services; pharmaceutical research and development; development of pharmaceutical products; evaluation of results from quality control tests conducted on goods and services in relation to pharmaceutical products; consulting with regard to pharmacology; laboratory research services with regard to pharmaceuticals; research in the field of pharmaceuticals; consulting with regard to pharmaceutical research and development; scientific research in the field of pharmacy; pharmaceutical product evaluationservices for the evaluation of the therapeutic effects of pharmaceuticals; new product research and development services for the pharmaceutical industry; research and development in the field of pharmacy and biotechnology; information technology (IT) consultancy services for pharmaceutical industry and health sector; quality assessment in the nature of quality testinganalysis and evaluation with regard to research in the field of pharmacogenetics; biochemical research; biological research; biological analysis; biological research services; biological development services being biological research and analysis; biological laboratory services; biochemical analysis; biomedical research; biotechnological research; research regarding biotechnologies; biotechnological research services; scientific research regarding biology; biological research and analysis; research in the field of biotechnology; consulting in the field of biology; consulting in the field of biochemistry; research and development in the field of biochemistry; research and development services in the field of biotechnology
Classe 44
Medical services; medical services of a health clinic; medical services and health care; medical services of a health farm; health care services of a medical health resort; medical agency servicesmedical services; medical services for charity purpose; medical services in the field of nephrology; medical services in the field of oncology; medical services in the field of diabetes; medical reporting servicesservices for drawing up medical reports; medical servicesin-vitro insemination; medical servicesin vitro fertilization; medical services in the context of house calls; medical services for the treatment of the skin; consulting services in the field of medical care; medical screening-services concerning cardiovascular diseases; provision of medical information concerning medical services; services of medical clinics and health clinics; medical services for the treatment of skin cancer; providing medical information concerning medical services; medical services for people in need in the context of charity; medical services for the treatment of diseases of the human body; medical services for the diagnosis of the condition of the human body; medical services in the field of the treatment of chronic pain; medical services and health care concerning DNAgenetics and genetic tests; medical services concerning the extractiontreatment and processing of bone marrow; medical services concerning the extractiontreatment and processing of stem cells; medical services concerning the extractiontreatment and processing of cord blood; medical services concerning the extractiontreatment and processing of human cells; medical services concerning the extractiontreatment and processing of human blood
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/10/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
19/11/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/02/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
27/01/2020
FIMP
FINAL DISPOSITION PROCESSED
27/01/2020
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/01/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/01/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
01/10/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/07/2019
PUBO
PUBLISHED FOR OPPOSITION
16/07/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/06/2019
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
04/06/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/04/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/04/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
28/02/2019
GNRT
NON-FINAL ACTION E-MAILED
28/02/2019
CNRT
NON-FINAL ACTION WRITTEN
28/02/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/12/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/12/2018
ALIE
ASSIGNED TO LIE
20/12/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/12/2018
RFNT
REFUSAL PROCESSED BY IB
09/07/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/06/2018
RFRR
REFUSAL PROCESSED BY MPU
18/06/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/06/2018
CNRT
NON-FINAL ACTION WRITTEN
10/06/2018
MAFR
APPLICATION FILING RECEIPT MAILED
29/05/2018
DOCK
ASSIGNED TO EXAMINER
25/05/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/05/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/05/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ATTYLOID ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.